BI
The startup develops optimized parental cells for the production of stem cell exosomes, which have superior proliferation and secretion capabilities. This technology enables mass production of exosomes, providing a scalable solution for targeting incurable diseases.
Updated 3 months ago
Funding
$25.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops optimized parental cells for the production of stem cell exosomes, which have superior proliferation and secretion capabilities. This technology enables mass production of exosomes, providing a scalable solution for targeting incurable diseases.